# Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma

> **NCT00416832** · PHASE2 · COMPLETED · sponsor: **Christine Mauz-Körholz** · enrollment: 648 (estimated)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** cyclophosphamide
- **DRUG:** dacarbazine
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide
- **DRUG:** prednisone
- **DRUG:** procarbazine hydrochloride
- **DRUG:** vincristine sulfate
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00416832
- **Lead sponsor:** Christine Mauz-Körholz
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2005-12
- **Final completion:** 2005-12
- **Target enrollment:** 648 (ESTIMATED)
- **Last updated:** 2020-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00416832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00416832, "Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00416832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*